Company profile for Novasep

PharmaCompass
Related CompaniesRelated Companies

About

Axplora, created from the merger of Farmabios, Novasep & PharmaZell, is a leading API manufacturing partner to the world’s leading pharma & biotech companies, delivering top-quality APIs on time & at scale, to the highest industry standards. It is dedicated to helping pharma companies make critical medicines safely to benefit patients. Leveraging our combined expertise & manufacturing capabilities across 9 industrial sites in the EU & India & an R&D facility in the USA, it offers CDMO services for small molecule APIs & biopharmaceuticals to innovators as well as APIs that address lifestyle-induced respiratory, inflammatory & liver diseases.

CONTACT DETAILS

Click the arrow to open the dropdown

Events

Webinars & Exhibitions

Default Event

CPhI WW Frankfurt

Not Confirmed

envelop Contact Supplier

CPhI WW Frankfurt

Post an Enquiry

Meeting

Digital content read-more

Explore the latest content creation from this company

NEWS #PharmaBuzz

read-more
read-more

https://www.axplora.com/scientific-advisory-board/

PRESS RELEASE
13 Nov 2023

https://www.axplora.com/scientific-advisory-board/

PRESS RELEASE
13 Nov 2023

https://www.axplora.com/axplora-appoints-dr-stephan-haitz-as-president-of-its-novasep-cdmo-business-unit/

PRESS RELEASE
18 Oct 2023

01

Adapalene

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

USDMF CEP/COS JDMF EU-WC NDC KDMF arrow-down VMF Others AUDIT
Axplora Novasep

02

Adapalene

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

USDMF CEP/COS JDMF EU-WC NDC KDMF arrow-down VMF Others AUDIT
Axplora Novasep

03

Brinzolamide

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

USDMF CEP/COS JDMF EU-WC NDC KDMF arrow-down VMF Others AUDIT
Axplora Novasep
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

read-more
read-more

01

Novasep

Registrant Name : Galderma Korea Co., Ltd.

Registration Date : 2024-03-27

Registration Number : 20240327-209-J-1630

Manufacturer Name : FINORGA SAS

Manufacturer Address : Route de Givors Chasse Sur Rhone,38670, France

Axplora Novasep

02

Novasep

Registrant Name : Galderma Korea Co., Ltd.

Registration Date : 2023-08-24

Registration Number : 20230824-209-J-1526

Manufacturer Name : FINORGA SAS

Manufacturer Address : route de Givors Chasse Sur Rhone,38670, France

Axplora Novasep

03

Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Through the agreement, Novasep will support Celladon’s plans to produce Mydicar, which is being evaluated in the mid-stage clinical trial for the treatment of heart failure.


Lead Product(s): AAV1/SERCA2a,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Mydicar

Study Phase: Phase IIProduct Type: Cell and Gene therapy

Sponsor: Celladon

Deal Size: $5.4 million Upfront Cash: Undisclosed

Deal Type: Agreement December 13, 2023

Axplora Novasep

01

Novasep

Germany
arrow

Details : Through the agreement, Novasep will support Celladon’s plans to produce Mydicar, which is being evaluated in the mid-stage clinical trial for the treatment of heart failure.

Product Name : Mydicar

Product Type : Cell and Gene therapy

Upfront Cash : Undisclosed

December 13, 2023

Axplora Novasep

Details:

Novasep has successfully optimized and scaled-up the process of Adcitmer® (monomethyl auristatin E-conjugated antibody), McSAF Inside® Oncology’s first-in-class proprietary ADC to treat neuroendocrine cancers.


Lead Product(s): Adcitmer,Inapplicable

Therapeutic Area: Oncology Brand Name: Adcitmer

Study Phase: PreclinicalProduct Type: Antibody-drug Conjugate

Recipient: McSAF

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration November 18, 2021

Axplora Novasep

02

Novasep

Germany
arrow

Details : Novasep has successfully optimized and scaled-up the process of Adcitmer® (monomethyl auristatin E-conjugated antibody), McSAF Inside® Oncology’s first-in-class proprietary ADC to treat neuroendocrine cancers.

Product Name : Adcitmer

Product Type : Antibody-drug Conjugate

Upfront Cash : Undisclosed

November 18, 2021

Axplora Novasep

Details:

The agreement aims for the manufacturing of adeno-associated virus (AAV) vectors, covering the gene therapy program targeting OTOF (OTOF-GT), the gene encoding the otoferlin protein and aims to restore the expression of Otoferlin.


Lead Product(s): OTOF-GT,Inapplicable

Therapeutic Area: Otolaryngology (Ear, Nose, Throat) Brand Name: OTOF-GT

Study Phase: PreclinicalProduct Type: Cell and Gene therapy

Sponsor: Sensorion

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement November 03, 2020

Axplora Novasep

03

Novasep

Germany
arrow

Details : The agreement aims for the manufacturing of adeno-associated virus (AAV) vectors, covering the gene therapy program targeting OTOF (OTOF-GT), the gene encoding the otoferlin protein and aims to restore the expression of Otoferlin.

Product Name : OTOF-GT

Product Type : Cell and Gene therapy

Upfront Cash : Undisclosed

November 03, 2020

Axplora Novasep
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Contact Novasep and get a quotation

Novasep is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of Adapalene bulk offered by Novasep

Find a price of Brinzolamide bulk offered by Novasep

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty